Prostate Cancer News
- Watch and Wait a Safe Approach for Prostate Cancer
March 12, 2023 — Actively monitoring early-stage prostate cancer offers the same long-term survival rate as having surgery or radiation to treat the cancer, according to a new study.
- Digital Rectal Exams Could Miss Early Prostate Cancers: Study
March 9, 2023 — The study found that a PSA test at age 50 detected four times as many cases of early prostate cancer as a digital rectal exam at age 45 alone.
- Mental Distress: Prostate Cancer’s ‘Elephant in the Room’
November 2, 2022 — Mental distress has been called the “elephant in the room” for patients with prostate cancer that doesn’t require treatment right away. For years, these concerns were largely ignored, according to advocates and health professionals.
- Most Men With Low-Risk Prostate Tumors Now Forgoing Treatment
May 17, 2022 — Acceptance of active surveillance for low-risk prostate cancer hit a record high in 2021, although the U.S. still lags internationally, new figures showed.
- ‘Joe Exotic’ Says He Has Prostate Cancer
November 5, 2021 — Joseph Maldonado-Passage, better known as “Joe Exotic” on the Netflix docuseries Tiger King, announced on social media that he’s been diagnosed with an aggressive form of prostate cancer.
- Could AI help improve prostate cancer treatment?
November 7, 2017 — Artificial intelligence (AI) could be used to personalise treatment for prostate cancer and reduce the number of men who undergo serious side-effects as a result of radiotherapy, a cancer conference has been told.
- Prostate cancer 'riskier for tall and obese men'
July 13, 2017 — Tall men and those who are obese have a higher risk of high grade prostate cancer and dying from the disease, a study has found.
- Surgery or Radiation: Which Is Better for Early Prostate Cancer?
October 2, 2000 — When Hank Porterfield learned he had prostate cancer in 1992, he was faced with a critical choice that more than 100,000 men in the U.S. make each year -- whether to treat the cancer with surgery or radiation.